Novo Nordisk NOVO.B -0.83%decrease; down pointing triangle said its Wegovy injection helped children with obesity shed weight in a clinical trial, with two out of five participants no longer classified as having the condition after 68 weeks of treatment.
The Danish drugmaker said Monday that the study showed 40.4% of children aged 6 to under 12 years with obesity who were treated with Wegovy in combination with a lower-calorie diet and increased physical activity reduced their body mass index to levels considered normal or overweight after 68 weeks.
Copyright ©2026 Dow Jones & Company, Inc. All Rights Reserved. 87990cbe856818d5eddac44c7b1cdeb8